Syon Capital’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$53.9K Hold
18,501
– – ﹤0.01% 1079
2026
Q2
$64.6K Buy
18,501
+1,838
+11% +$5.92K ﹤0.01% 945
2026
Q1
$48K Hold
16,663
– – ﹤0.01% 903
2025
Q4
$67.8K Hold
16,663
– – ﹤0.01% 892
2025
Q3
$59.2K Hold
16,663
– – ﹤0.01% 810
2025
Q2
$45.5K Sell
16,663
-6,203
-27% -$12.8K ﹤0.01% 725
2025
Q1
$38.4K Buy
22,866
+6,203
+37% +$17.3K ﹤0.01% 580
2024
Q4
$27.2K Buy
+16,663
New +$49.7K ﹤0.01% 561

Other funds holding SANA

Syon Capital's SANA Position: Q3 2026 in Review

Syon Capital held its Sana Biotechnology (SANA) position steady in Q3 2026 at 18,501 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1079.

Syon Capital first reported a position in SANA in Q4 2024 and has held it in 8 quarters since. The position peaked at $67.8K in Q4 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • Syon Capital held 18,501 shares of Sana Biotechnology worth $53.9K as of Q3 2026.
  • Syon Capital left its Sana Biotechnology share count unchanged in Q3 2026.
  • Sana Biotechnology made up ﹤0.01% of Syon Capital's portfolio in Q3 2026, its #1079 holding.
  • Syon Capital first reported a position in Sana Biotechnology in Q4 2024 and has held it in 8 quarters since.
  • Syon Capital's Sana Biotechnology position peaked at $67.8K in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.